News
-
Creative Biolabs Enhances iPSC Differentiation Portfolio to Accelerate Neuroscience and Regenerative Medicine Research
Creative Biolabs announces the highlight of its comprehensive induced pluripotent stem cell (iPSC) differentiation services designed to support cutting-edge biomedical research. -
Creative Diagnostics Strengthens Preclinical Support with Advanced Coronavirus Animal Model Services for Antiviral Research
Creative Diagnostics announces the release of its Coronavirus Animal Model services to help scientists to evaluate the pathogenicity and transmissibility of Coronavirus. -
CD Bioparticles Launches Innovative Organoid Culture Tools to Advance 3D Disease Modeling and Drug Discovery
CD Bioparticles announces the launch of its comprehensive line of Organoid Culture Tools. -
Creative Biolabs Advances Oncology Frontiers with Next-Generation Synthetic Carbohydrate-Based Cancer Vaccine Platforms
Creative Biolabs has announced a strategic expansion of its cancer vaccine research platforms, focusing on the sophisticated design and synthesis of tumor-associated carbohydrate antigens (TAGAs). -
Creative Biolabs Unveils Integrated Microfluidic Solutions Synergizing Neuron-on-a-Chip and Advanced Cell Sorting
Creative Biolabs' one-stop microfluidic platform accelerates biomedical breakthroughs by streamlining chip innovation for faster, scalable, and physiologically relevant discoveries. -
Creative Biolabs Unveils LNP Conjugation Platforms to Advance Precision Gene Therapy
Creative Biolabs announced the launch of its enhanced lipid nanoparticle (LNP) conjugation platform—solving long‑standing challenges in nucleic acid delivery for gene therapy and RNA‑based therapeutics. -
Optimal Research Sites Joins hyperCORE International's Global Partner Site Network
The Central Florida-based clinical research organization brings decades of experience, strong enrollment, and community-centered research to hyperCORE's expanding global network -
Ace Therapeutics Launches Comprehensive Ocular Toxicology Services to Accelerate Ophthalmic Drug Development
Ace Therapeutics launches its full suite of ocular toxicology services to support global pharmaceutical and biotech clients in advancing safe and effective ophthalmic therapies. -
Clym Environmental Announces New Frostburg Facility in Recognition of Earth Day
Deployment of the company's proprietary solar and ozone technology marks a milestone for sustainable life sciences waste management -
Advancing Biotherapeutic Efficacy: Creative Biolabs Engineering High-Affinity Biobetters via Targeted Glyco-Modification and Precision ADCC Analysis
Creative Biolabs, a global leader in antibody engineering, has announced the expansion of its integrated suite of solutions focused on antibody-dependent cellular cytotoxicity (ADCC).